X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (613) 613
Publication (86) 86
Book Chapter (5) 5
Book / eBook (3) 3
Book Review (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mucosal leishmaniasis (445) 445
humans (375) 375
index medicus (333) 333
animals (239) 239
cutaneous leishmaniasis (212) 212
leishmaniasis (212) 212
male (207) 207
immunology (205) 205
female (197) 197
adult (158) 158
infectious diseases (150) 150
middle aged (138) 138
tropical medicine (131) 131
parasitology (130) 130
parasitic diseases (119) 119
visceral leishmaniasis (115) 115
microbiology (113) 113
infection (108) 108
leishmaniasis, cutaneous - immunology (97) 97
mice (93) 93
mucocutaneous leishmaniasis (88) 88
diagnosis (81) 81
infections (80) 80
cytokines (77) 77
leishmania braziliensis (77) 77
parasites (77) 77
adolescent (76) 76
antiprotozoal agents - therapeutic use (76) 76
aged (70) 70
research article (69) 69
health aspects (65) 65
leishmaniasis, cutaneous (65) 65
leishmaniasis, cutaneous - parasitology (65) 65
immune response (64) 64
leishmania (64) 64
research (64) 64
young adult (64) 64
leishmaniasis, cutaneous - drug therapy (62) 62
antigens (59) 59
care and treatment (57) 57
public, environmental & occupational health (57) 57
american cutaneous leishmaniasis (56) 56
leishmaniasis, cutaneous - pathology (56) 56
interferon-gamma (54) 54
analysis (52) 52
immune-responses (51) 51
arctic medicine. tropical medicine (50) 50
child (50) 50
lesions (48) 48
medicine (48) 48
vaccines (48) 48
expression (45) 45
dermatology (44) 44
tropical diseases (44) 44
braziliensis (43) 43
dendritic cells (43) 43
american tegumentary leishmaniasis (42) 42
leishmania braziliensis - immunology (42) 42
leishmaniasis, cutaneous - epidemiology (41) 41
lymphocytes (41) 41
t-cells (40) 40
vaccination (40) 40
antigens, protozoan - immunology (39) 39
efficacy (39) 39
polymerase chain reaction (39) 39
treatment outcome (39) 39
brazil (38) 38
leishmaniasis, mucocutaneous - drug therapy (38) 38
macrophages (38) 38
mice, inbred balb c (38) 38
viannia braziliensis (38) 38
leishmaniasis, cutaneous - diagnosis (37) 37
responses (37) 37
tegumentary leishmaniasis (37) 37
t cells (36) 36
vector-borne diseases (36) 36
immunity (35) 35
immunization (35) 35
leishmaniasis, mucocutaneous - parasitology (35) 35
aged, 80 and over (34) 34
meglumine antimoniate (34) 34
mucosal (34) 34
sodium stibogluconate (34) 34
immune-response (33) 33
pathology (33) 33
disease models, animal (32) 32
epidemiology (31) 31
leishmaniasis, mucocutaneous - immunology (31) 31
mice, inbred c57bl (31) 31
article (30) 30
immune system (30) 30
in-vitro (30) 30
medicine and health sciences (30) 30
miltefosine (30) 30
biology and life sciences (29) 29
inflammation (29) 29
kala-azar (29) 29
leishmaniasis, mucocutaneous - diagnosis (29) 29
lymphocytes t (29) 29
mucosa (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Dermatologic Clinics, ISSN 0733-8635, 2015, Volume 33, Issue 3, pp. 579 - 593
Journal Article
Annales de Dermatologie et de Venereologie, ISSN 0151-9638, 03/2019, Volume 146, Issue 3, pp. 232 - 246
Cutaneous leishmaniasis is a parasitic infection caused by a flagellated parasite belonging to the genus Leishmania. In most cases, it is a zoonotic disease... 
Cutaneous leishmaniasis | Diffuse leishmaniasis | Leishmaniasis | Mucosal leishmaniasis | Post-kala-azar leishmaniasis
Journal Article
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, ISSN 0151-9638, 03/2019, Volume 146, Issue 3, pp. 232 - 246
Cutaneous leishmaniasis is a parasitic infection caused by a flagellated parasite belonging to the genus Leishmania. In most cases, it is a zoonotic disease... 
DIAGNOSIS | PARASITES | EFFICACY | Diffuse leishmaniasis | PERSISTENCE | Leishmaniasis | DERMATOLOGY | Cutaneous leishmaniasis | Post-kata-azar leishmaniasis | TEGUMENTARY LEISHMANIASIS | Mucosat leishmaniasis | MUCOSAL LEISHMANIASIS | INFANTUM
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 10/2015, Volume 28, Issue 5, pp. 426 - 437
PURPOSE OF REVIEWThis review summarizes recent important and interesting articles investigating the challenging treatment of the parasitic infection,... 
treatment | practice guidelines | cutaneous leishmaniasis | visceral leishmaniasis | Leishmania | DAC N-055 | INFECTIOUS DISEASES | RISK-FACTORS | HIV COINFECTION | DERMAL LEISHMANIASIS | LIPOSOMAL AMPHOTERICIN-B | THERAPY | MUCOSAL LEISHMANIASIS | KALA-AZAR | Leishmaniasis - therapy | Humans | Trypanocidal Agents | Practice Guidelines as Topic
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 11/2017, Volume 11, Issue 11, p. e0006094
Background Complex cutaneous and muco-cutaneous leishmaniasis (CL and MCL) often requires systemic therapy. Liposomal amphotericin B (L-AmB) has a strong... 
AMBISOME | BRAZILIENSIS | PHARMACOKINETICS | MUCOSAL LEISHMANIASIS | MEGLUMINE ANTIMONIATE | EXPERIENCE | INFECTION | SODIUM STIBOGLUCONATE | FORMULATION | VISCERAL LEISHMANIASIS | PARASITOLOGY | TROPICAL MEDICINE | Humans | Middle Aged | Child, Preschool | Infant | Male | Leishmania - classification | Aged, 80 and over | Amphotericin B - administration & dosage | Leishmania - drug effects | Adult | Female | Retrospective Studies | Child | Leishmaniasis, Mucocutaneous - parasitology | Treatment Outcome | Leishmaniasis, Cutaneous - drug therapy | Amphotericin B - adverse effects | Travel | Leishmaniasis, Mucocutaneous - drug therapy | Antiprotozoal Agents - adverse effects | Leishmaniasis, Cutaneous - parasitology | Adolescent | Antiprotozoal Agents - administration & dosage | Aged | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Care and treatment | Leishmaniasis, Cutaneous | Amphotericin B | Analysis | Travelers | Dosage and administration | Health aspects | Vector-borne diseases | Therapy | Countries | Medical services | Data processing | Infections | Duration | Leishmaniasis | Multivariate analysis | Patients | Consortia | Cutaneous leishmaniasis | Parasitic diseases | Travellers | Failure analysis | Healing | Lesions | Health risk assessment | Heart diseases | Health | Leishmaniasis, Mucocutaneous | Life Sciences | Antiprotozoal Agents | Leishmania | Ecology, environment
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 06/2013, Volume 133, Issue 6, pp. 1533 - 1540
Journal Article